North America
International Markets
North America
Toggle North America
International Markets
Toggle International Markets
Europe
Toggle Europe
Study in Patients' With Persistent Asthma and Chronic Obstructive Pulmonary Disease
- Study Title
- Study in Patients' With Persistent Asthma and Chronic Obstructive Pulmonary Disease
- Teva Identifier
- BFS-AS-40087
- ClinicalTrials.gov Identifier
- NCT02419872
- Study Status
- Completed
- Trial Condition(s)
- Asthma | Chronic Obstructive Pulmonary Disease
- Interventions
- Drug: Marketed antagonists
Study Description
Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
- Gender
- Female, Male
- Age group
- Adult, Older Adult
- Age Range
- 18 Years and older
- Trial Duration
- 05/31/2015 - 04/07/2017
